Ashley N. Davis

715 citations
10 papers · 565 indexed · h-index 8
Topics
Genetic Neurodegenerative Diseases (3 papers)Botulinum Toxin and Related Neurological Disorders (2 papers)Angiogenesis and VEGF in Cancer (2 papers)

In The Last Decade

Ashley N. Davis

10 papers receiving 559 citations

Peers

Ashley N. Davis
Comparison fields: 5 of 63
  • Molecular Biology 354
  • Cellular and Molecular Neuroscience 223
  • Immunology 146
  • Neurology 126
  • Oncology 121
Replace Pin Ouyang with:
Pin Ouyang Taiwan
Ernest Smith United States
Thomas Koed Doktor Denmark
Elsa Regan‐Klapisz Netherlands
Yumiko Azuma Japan
Kimiyoshi Arimura Japan
Israel Ben‐Dor Israel
Sigve Nakken Norway
Sang Mi Shim South Korea
Lara Paracchini Italy
Ashley N. Davis relative to Pin Ouyang Taiwan Pin Ouyang's profile →
Citations per field
00.5×3.2×
Pin Ouyang · 1×
Citations per year

Countries citing papers authored by Ashley N. Davis

Since Specialization
Citations

This map shows the geographic impact of Ashley N. Davis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ashley N. Davis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ashley N. Davis more than expected).

Fields of papers citing papers by Ashley N. Davis

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ashley N. Davis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ashley N. Davis. The network helps show where Ashley N. Davis may publish in the future.

Co-authorship network of co-authors of Ashley N. Davis

This figure shows the co-authorship network connecting the top 25 collaborators of Ashley N. Davis. A scholar is included among the top collaborators of Ashley N. Davis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ashley N. Davis. Ashley N. Davis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
#WorkIndexed citations
1 4
2 20
3 223
4 11
5 4
6 15
7 51
8 74
9 64
10 99

About Ashley N. Davis

Ashley N. Davis is a scholar working on Aging, Neurology and Cellular and Molecular Neuroscience, having authored 10 papers that have together received 565 indexed citations. Recurring topics across this work include Genetic Neurodegenerative Diseases (3 papers), Botulinum Toxin and Related Neurological Disorders (2 papers) and Angiogenesis and VEGF in Cancer (2 papers). The work is most often cited by research in Cellular and Molecular Neuroscience (223 citations), Neurology (126 citations) and Immunology (146 citations). Ashley N. Davis has collaborated with scholars based in United States, South Korea and Thailand. Frequent co-authors include Arnulf H. Koeppen, Anil K. Sood, Vahid Afshar‐Kharghan, Benjamin B. Gelman, Qian Jiang, Khushbu Bhatt, Nikhil Khatwani, Faith Musenge, Kristine Burke and W. M. Gibson. Their work appears in journals such as Clinical Cancer Research, Science Translational Medicine and Biomacromolecules.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026